| Article
Assessment, diagnosis, treatment plan formulation, implementation, and follow-up are processes familiar to clinicians and are the main drivers of safe and effective chronic pain treatment. However, many other things influence our clinical decision-making, including the continuing controversies about...
| Article
Why yet another lecture on migraine headaches, you ask? Migraine is the third most common disease in the world (behind dental caries and tension-type headache) with an estimated global prevalence of approximately 15% (that's around 1 in 7 people). Migraine is more prevalent than diabetes, epilepsy...
| Article
Breakfast will be served.
Sponsored by Teva Pharmaceuticals
*This session is not certified for credit.
| Article
Breakfast will be served.
*This session is not certified for credit.
| Article
Safety concerns, new warnings, and new formulations focused on harm reduction have led many providers to question NSAIDs place in therapy. NSAIDs have been a cornerstone of pain management of inflammatory, connective tissue, and autoimmune disorders for over a hundred years. A historical perspective...
| Article
Nonopioid analgesics are considered first-line therapy for most chronic pain syndromes. A strong recall of these agents’ safety and efficacy profiles is paramount for today’s pain practitioner. This course will provide an in-depth look at each of the agents within these drug classes, their potential...